Prognostic value of plasma B-type natriuretic peptide in patients with severe cardiotoxic drug poisoning

References

• Baud FJ, Megarbane B, Deye N, Leprince P. Clinical review: Aggressive management and extracorporeal support for drug-induced cardiotoxicity. Crit Care. 2007;11:207.
   PubMed Web of Science ®Google Scholar
• Bronstein AC, Spyker DA, Cantilena LR, Jr, Green JL, Rumack BH, Giffin SL. 2009 Annual report of the American Association of Poison Control Centers’ national poison data system (NPDS): 27th Annual Report. Clin Toxicol (Phila). 2009;48:979–1178.
   Google Scholar
• Maisel AS. Practical approaches to treating patients with acute decompensated heart failure. J Card Fail. 2001;7(Suppl. 1):13–7.
   Google Scholar
• Maisel AS. The diagnosis of acute congestive heart failure: Role of BNP measurements. Heart Fail Rev. 2003;8:327–34.
   PubMed Web of Science ®Google Scholar
• Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357–68.
   PubMed Web of Science ®Google Scholar
• Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, . NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: An international pooled analysis of 1256 patients: The international collaborative of NT-proBNP study. Eur Heart J. 2006;27:330–7.
   PubMed Web of Science ®Google Scholar
• Maisel A, Mueller C, Adams K, Jr, Anker SD, Aspromonte N, Cleland JG, . State of the art: Using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10:824–39.
   PubMed Web of Science ®Google Scholar
• Muders F, Kromer EP, Griese DP, Pfeifer M, Hense HW, Riegger GA, . Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J. 1997;134:442–9.
   PubMed Web of Science ®Google Scholar
• Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, . Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004;43:635–41.
   PubMed Web of Science ®Google Scholar
• de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, . The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014–21.
   PubMed Web of Science ®Google Scholar
• Choy AM, Darbar D, Lang CC, Pringle TH, McNeill GP, Kennedy NS, . Detection of left ventricular dysfunction after acute myocardial infarction: Comparison of clinical, echocardiographic, and neurohormonal methods. Br Heart J. 1994;72:16–22.
   PubMedGoogle Scholar
• Logeart D, Lecuyer L, Thabut G, Tabet JY, Tartiere JM, Chavelas C, . Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism. Intensive Care Med. 2007;33:286–92.
   Google Scholar
• Nagao K, Hayashi N, Kanmatsuse K, Kikuchi S, Kikushima K, Watanabe K, . B-type natriuretic peptide as a marker of resuscitation in patients with cardiac arrest outside the hospital. Circ J. 2004;68:477–82.
   Google Scholar
• Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med. 1994;330:1724–30.
   PubMed Web of Science ®Google Scholar
• Resnekov L. Cardiogenic shock. Chest 1983;83:893–8.
   Google Scholar
• Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, . ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388–442.
   PubMed Web of Science ®Google Scholar
• Albertson TE, Dawson A, de Latorre F, Hoffman RS, Hollander JE, Jaeger A, . TOX-ACLS: Toxicologic-oriented advanced cardiac life support. Ann Emerg Med. 2001;37(Suppl.):S78–90.
   Google Scholar
• Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, . Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327.
   PubMed Web of Science ®Google Scholar
• de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316–22.
   PubMed Web of Science ®Google Scholar
• Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321–8.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Fujiwara H, Doyama K, Miyamae M, Fujiwara T, Suga S, . Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 1993;88:372–80.
   PubMedGoogle Scholar
• Yoshibayashi M, Kamiya T, Saito Y, Matsuo H. Increased plasma levels of brain natriuretic peptide in hypertrophic cardiomyopathy. N Engl J Med. 1993;329:433–4.
   Google Scholar
• Lam SM, Lau AC, Yan WW. Over 8 years experience on severe acute poisoning requiring intensive care in Hong Kong, China. Hum Exp Toxicol. 2010.
   Google Scholar
• Pirracchio R, Deye N, Lukaszewicz AC, Mebazaa A, Cholley B, Mateo J, . Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med. 2008;36:2542–6.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li C. Prognostic significance of brain natriuretic peptide obtained in the ED in patients with SIRS or sepsis. Am J Emerg Med. 2009;27:701–6.
   Google Scholar
• Meyer B, Huelsmann M, Wexberg P, Delle Karth G, Berger R, Moertl D, . N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med. 2007;35:2268–73.
   PubMed Web of Science ®Google Scholar
• Sodeck GH, Domanovits H, Sterz F, Schillinger M, Losert H, Havel C, . Can brain natriuretic peptide predict outcome after cardiac arrest? An observational study. Resuscitation 2007;74:439–45.
   PubMed Web of Science ®Google Scholar
• Pach D, Gawlikowski T, Targosz D, Groszek B, Wilimowska J. B-type natriuretic peptide plasma concentration in acutely poisoned patients. Przegl Lek. 2005;62:465–7.
   PubMedGoogle Scholar
• Cohen-Solal A, Logeart D, Huang B, Cai D, Nieminen MS, Mebazaa A. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure. J Am Coll Cardiol. 2009;53:2343–8.
   PubMed Web of Science ®Google Scholar
• Gackowski A, Isnard R, Golmard JL, Pousset F, Carayon A, Montalescot G, . Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur Heart J. 2004;25:1788–96.
   PubMed Web of Science ®Google Scholar
• Cosentini R, Folli C, Cazzaniga M, Aliberti S, Piffer F, Grazioli L, . Usefulness of simplified acute physiology score II in predicting mortality in patients admitted to an emergency medicine ward. Intern Emerg Med. 2009;4:241–7.
   PubMed Web of Science ®Google Scholar